New developments in the treatment of hyperammonemia: emerging use of carglumic acid.
about
Recurrent encephalopathy: NAGS (N-acetylglutamate synthase) deficiency in adults.Innovative therapy for Classic Galactosemia - tale of two HTS.Molecular mechanisms of protein induced hyperinsulinaemic hypoglycaemia.Carglumic acid promotes apoptosis and suppresses cancer cell proliferation in vitro and in vivo.Carglumic acid enhances rapid ammonia detoxification in classical organic acidurias with a favourable risk-benefit profile: a retrospective observational studyMitochondrial carbonic anhydrase VA deficiency resulting from CA5A alterations presents with hyperammonemia in early childhood.Clinical experience with N-carbamylglutamate in a single-centre cohort of patients with propionic and methylmalonic aciduria.Potential role of N-carbamoyl glutamate in biosynthesis of arginine and its significance in production of ruminant animals.Hyperammonemic encephalopathy in an adenocarcinoma patient managed with carglumic acidThe Pharmabiotic Approach to Treat Hyperammonemia.Precision medicine in rare disease: Mechanisms of disparate effects of N-carbamyl-l-glutamate on mutant CPS1 enzymes.Effect of carglumic acid with or without ammonia scavengers on hyperammonaemia in acute decompensation episodes of organic acidurias.Ginkgo biloba extract and its diterpene ginkgolide constituents ameliorate the metabolic disturbances caused by recombinant tissue plasminogen activator in rat prefrontal cortex.Acute pediatric hyperammonemia: current diagnosis and management strategies
P2860
Q34039333-5A4142EF-79A8-4763-91BA-D293B3EA799EQ34054239-0B5C900F-4ECC-4F4A-B12B-7F0C3CD8B73CQ34068441-2047B64D-FB18-4EF1-958E-F1A45ED6A1D6Q36516568-52B46DB7-CAB4-4C53-9EFC-288D119B75C2Q36748949-C37FD10A-9BD6-479B-BD53-E02CE6B7DCF1Q37634124-3408A0B8-6BAB-4DF5-8CC3-CA31D47ED21BQ39526121-A78F66A2-1598-44B6-9E8C-71403AFAFAF6Q39876867-41168460-B266-4E70-9944-5D27D9AE358FQ42036213-334B027C-14ED-4C61-A7AB-D0A230AF5B4EQ47831420-06719BE2-C35F-47D2-9662-EFA70D0C2A45Q51241951-E8F1FA76-AB67-48AB-8F93-8BDDCD2312ABQ55455185-A530CB8F-4002-45E7-A31E-FCD65EF09D40Q55714791-23F0FDF8-9156-416C-B928-F1008F221AFDQ58424144-0D363DFB-E18D-417D-B7AC-5780E42E7335
P2860
New developments in the treatment of hyperammonemia: emerging use of carglumic acid.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 07 January 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
New developments in the treatment of hyperammonemia: emerging use of carglumic acid.
@en
New developments in the treatment of hyperammonemia: emerging use of carglumic acid.
@nl
type
label
New developments in the treatment of hyperammonemia: emerging use of carglumic acid.
@en
New developments in the treatment of hyperammonemia: emerging use of carglumic acid.
@nl
prefLabel
New developments in the treatment of hyperammonemia: emerging use of carglumic acid.
@en
New developments in the treatment of hyperammonemia: emerging use of carglumic acid.
@nl
P2860
P356
P1476
New developments in the treatment of hyperammonemia: emerging use of carglumic acid
@en
P2093
Marta Daniotti
Patrizio Fiorini
P2860
P356
10.2147/IJGM.S10490
P407
P577
2011-01-07T00:00:00Z